Editorial Policy

Here's our editorial policy, our policy on sponsorship and advertising, and our disclosures.

1. We adhere to strict editorial independence - our opinions are our own.
2. We do not take money to advertise any products.
3. Close Concerns' new service and all other publications is based on public information only. Close Concerns has ongoing business relationships with and/or holds stock in the following companies and organizations: Abbott, American Diabetes Association, Amylin, Alkermes, Asante, Avalere, Baxter, Bayer, Becton Dickinson, Biocon, Biodel, BodyMedia, Boehringer-Ingelheim, Calibra, CanAm, Catabasis, Cebix, Cellnovo, CeQur, Dexcom, The Endocrine Society, Enject, Eli Lilly, GI Dynamics, Gilead, GSK, Insulet, InteKrin, Intuity Medical, JDFR, J&J, McKinsey & Company, Medtronic, Merck, Mesoblast, Metabolex, Novartis, Novo Nordisk, Orexigen, Pfizer, PhaseBio, Proteus Biomedical, Reata, Roche, Rhythm, Sanofi, Sensors for Medicine and Science, Servier, Tandem Diabetes, Telcare, Thermalin, Unomedical, Valeritas, Vivus, and Xeris. Editorial content for Closer Look, Diabetes Close Up, and diaTribe is independent of these relationships. For any questions on our disclosure, please call +1 415 241 9500 or contact info(at)closeconcerns.com.